Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L McCall

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
World Journal of Surgery|July 5, 2007
Liver resection for hepatocellular carcinoma in a hepatitis B endemic areaAdam St J R Bartlett, John L McCall, Jonathan B Koea, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|January 26, 2021
The Epigenetic landscape of Circulating tumour cellsSai Shyam Vasantharajan, Michael R Eccles, Euan J Rodger, et al.
Hepatology (Baltimore, Md.)|July 16, 2008
Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trialLindsay D Plank, Edward J Gane, Szelin Peng, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 11, 2002
Costimulatory blockade prevents early rejection, promotes lymphocyte apoptosis, and inhibits the upregulation of intragraft interleukin-6 in an orthotopic liver transplant model in the ratAdam S Bartlett, John L McCall, Rohan Ameratunga, et al.
Cancers|July 27, 2022
Assessment of a Size-Based Method for Enriching Circulating Tumour Cells in Colorectal CancerSai Shyam Vasantharajan, Edward Barnett, Elin S Gray, et al.
Annals of Surgery|October 21, 2016
Low Versus Standard Urine Output Targets in Patients Undergoing Major Abdominal Surgery: A Randomized Noninferiority TrialJevon R Puckett, John W Pickering, Suetonia C Palmer, et al.
Cancer Immunology, Immunotherapy : CII|January 25, 2017
Inclusion of BLIMP-1<sup>+</sup> effector regulatory T cells improves the Immunoscore in a cohort of New Zealand colorectal cancer patients: a pilot studyKirsten A Ward-Hartstonge, John L McCall, Timothy R McCulloch, et al.
International Journal of Cancer|May 13, 2018
Prognostic roles for IL-2-producing and CD69<sup>+</sup> T cell subsets in colorectal cancer patientsEdward S Taylor, John L McCall, Shirley Shen, et al.
The Journal of Surgical Research|October 24, 2003
Intragraft gene and protein expression in rat liver allografts treated with costimulatory blockade alone or in combination with CyAAdam S R Bartlett, John L McCall, Rohan Ameratunga, et al.
European Journal of Immunology|December 28, 2020
Human liver-derived MAIT cells differ from blood MAIT cells in their metabolism and response to TCR-independent activationRajesh Lamichhane, Fran Munro, Thomas W R Harrop, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
World Journal of Surgery|July 5, 2007
Liver resection for hepatocellular carcinoma in a hepatitis B endemic areaAdam St J R Bartlett, John L McCall, Jonathan B Koea, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|January 26, 2021
The Epigenetic landscape of Circulating tumour cellsSai Shyam Vasantharajan, Michael R Eccles, Euan J Rodger, et al.
Hepatology (Baltimore, Md.)|July 16, 2008
Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trialLindsay D Plank, Edward J Gane, Szelin Peng, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 11, 2002
Costimulatory blockade prevents early rejection, promotes lymphocyte apoptosis, and inhibits the upregulation of intragraft interleukin-6 in an orthotopic liver transplant model in the ratAdam S Bartlett, John L McCall, Rohan Ameratunga, et al.
Cancers|July 27, 2022
Assessment of a Size-Based Method for Enriching Circulating Tumour Cells in Colorectal CancerSai Shyam Vasantharajan, Edward Barnett, Elin S Gray, et al.
Annals of Surgery|October 21, 2016
Low Versus Standard Urine Output Targets in Patients Undergoing Major Abdominal Surgery: A Randomized Noninferiority TrialJevon R Puckett, John W Pickering, Suetonia C Palmer, et al.
Cancer Immunology, Immunotherapy : CII|January 25, 2017
Inclusion of BLIMP-1<sup>+</sup> effector regulatory T cells improves the Immunoscore in a cohort of New Zealand colorectal cancer patients: a pilot studyKirsten A Ward-Hartstonge, John L McCall, Timothy R McCulloch, et al.
International Journal of Cancer|May 13, 2018
Prognostic roles for IL-2-producing and CD69<sup>+</sup> T cell subsets in colorectal cancer patientsEdward S Taylor, John L McCall, Shirley Shen, et al.
The Journal of Surgical Research|October 24, 2003
Intragraft gene and protein expression in rat liver allografts treated with costimulatory blockade alone or in combination with CyAAdam S R Bartlett, John L McCall, Rohan Ameratunga, et al.
European Journal of Immunology|December 28, 2020
Human liver-derived MAIT cells differ from blood MAIT cells in their metabolism and response to TCR-independent activationRajesh Lamichhane, Fran Munro, Thomas W R Harrop, et al.
Pageof 5